Gilead Sciences Inc Reaches Exclusivity Deal With CVS For Hepatitis C Drugs

January 7, 2015 12:16 PM

13 0

Hepatitis C drug treatments are quickly becoming a hot ticket and now CVS has chosen to only carry one drug maker in this arena. On Monday, CVS Health Corp said that they have chosen to make Gilead Sciences Inc.’s hepatitis C drugs Sovaldi and Harvoni the only options for hepatitis C patients shopping for medicaitons.

CVS spokesman Christine K. Cramer, states “Our goal was to create the lowest net-cost solution for the entire population of patients with all genotypes of hepatitis C.”

Read more

To category page